Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

Revathi Badiginchala,1 Palanki Satya Dattatreya,1 Attili Venkata Satya Suresh,1 Sharanabasappa Somanath Nirni,1 Vindhya Vasini Andra,1 Deepak Bunger,2 Alok Chaturvedi2 1Medical Oncology, Omega Hospitals, Hyderabad, Telangana, India; 2Medical Affairs, Intas Pharmaceuticals Limited, Ahmedabad, IndiaCo...

Full description

Bibliographic Details
Main Authors: Badiginchala R, Dattatreya PS, Suresh AVS, Nirni SS, Andra VV, Bunger D, Chaturvedi A
Format: Article
Language:English
Published: Dove Medical Press 2023-04-01
Series:OncoTargets and Therapy
Subjects:
ndls
nanosomal docetaxel lipid suspension
docetaxel
breast cancer
operable
Online Access:https://www.dovepress.com/efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-ndls-versu-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-ndls-versu-peer-reviewed-fulltext-article-OTT

Similar Items